EMBO Molecular Medicine
Published on behalf of EMBO by Wiley-Blackwell
Indexed in Pubmed & ISI
- View Current Issue
- Free access in 2009 and 2010
- ask your librarian to register today
IN THIS ISSUE
![]()
Cycling through metabolism
Victor Aguilar and Lluis Fajas discuss the impact of cell cycle regulators on metabolic control and the relevance of these effects in the context of metabolic disorder.
Read review>>
![]()
Transglutaminase, transcription and Huntington's disease
McConoughey and colleagues show that transglutaminase inhibition normalizes expression of genes that are dysregulated in HD striatal neurons and ameliorates HD neurodegeneration.
Read article and related Closeup
Stem cell screen to identify neuroblastoma therapies
To identify compounds that selectively target patient-derived cancer stem cell-like cells, David Kaplan and colleagues perform a high-throughput cell-based screen and characterize compounds that selectively target neuroblastoma tumour initiating cells.
Read article>>
EDITORIAL
Transparency and accountability
EMBO Molecular Medicine is enriched by a number of innovative policies designed to enhance the editorial process: peer review process files, de‐emphasis of confidential referee comments and cross‐refereeing
Read editorial >>
Accepted Articles Express
![]()
Annexin A1 identified as metastasis suppressor
Read article>>
Virtual Issues
Read some of our exciting articles in the following areas
Cancer
Neurodegeneration
Stem Cells
Meet our senior editors
Journal Menu
-
Authors & Referees

.jpg)
